Nexalin Technology Stock Technical Analysis
| NXL Stock | USD 0.62 0.05 8.77% |
As of the 5th of February, Nexalin Technology secures the Mean Deviation of 3.9, standard deviation of 5.37, and Risk Adjusted Performance of (0.18). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nexalin Technology, as well as the relationship between them. Please verify Nexalin Technology risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Nexalin Technology is priced some-what accurately, providing market reflects its recent price of 0.62 per share. As Nexalin Technology is a penny stock we also strongly advise to check its jensen alpha numbers.
Nexalin Technology Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Nexalin, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NexalinNexalin Technology's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Nexalin Technology Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 4.0 | Buy | 1 | Odds |
Most Nexalin analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Nexalin stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Nexalin Technology, talking to its executives and customers, or listening to Nexalin conference calls.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. Anticipated expansion of Nexalin directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Nexalin Technology assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.65) | Revenue Per Share | Quarterly Revenue Growth (0.50) | Return On Assets | Return On Equity |
The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Nexalin Technology's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nexalin Technology should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Nexalin Technology's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Nexalin Technology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nexalin Technology's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nexalin Technology.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in Nexalin Technology on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding Nexalin Technology or generate 0.0% return on investment in Nexalin Technology over 90 days. Nexalin Technology is related to or competes with Inspira Technologies, Enlivex Therapeutics, Retractable Technologies, Collplant Biotechnologies, Harvard Bioscience, Vicarious Surgical, and Modular Medical. Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of ... More
Nexalin Technology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nexalin Technology's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nexalin Technology upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.26) | |||
| Maximum Drawdown | 27.45 | |||
| Value At Risk | (8.70) | |||
| Potential Upside | 7.92 |
Nexalin Technology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nexalin Technology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nexalin Technology's standard deviation. In reality, there are many statistical measures that can use Nexalin Technology historical prices to predict the future Nexalin Technology's volatility.| Risk Adjusted Performance | (0.18) | |||
| Jensen Alpha | (1.51) | |||
| Total Risk Alpha | (1.75) | |||
| Treynor Ratio | (0.48) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nexalin Technology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Nexalin Technology February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.18) | |||
| Market Risk Adjusted Performance | (0.47) | |||
| Mean Deviation | 3.9 | |||
| Coefficient Of Variation | (400.26) | |||
| Standard Deviation | 5.37 | |||
| Variance | 28.89 | |||
| Information Ratio | (0.26) | |||
| Jensen Alpha | (1.51) | |||
| Total Risk Alpha | (1.75) | |||
| Treynor Ratio | (0.48) | |||
| Maximum Drawdown | 27.45 | |||
| Value At Risk | (8.70) | |||
| Potential Upside | 7.92 | |||
| Skewness | 0.6008 | |||
| Kurtosis | 2.41 |
Nexalin Technology Backtested Returns
Nexalin Technology has Sharpe Ratio of -0.19, which conveys that the firm had a -0.19 % return per unit of risk over the last 3 months. Nexalin Technology exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Nexalin Technology's Risk Adjusted Performance of (0.18), mean deviation of 3.9, and Standard Deviation of 5.37 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 2.84, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Nexalin Technology will likely underperform. At this point, Nexalin Technology has a negative expected return of -1.06%. Please make sure to verify Nexalin Technology's potential upside and rate of daily change , to decide if Nexalin Technology performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.46 |
Average predictability
Nexalin Technology has average predictability. Overlapping area represents the amount of predictability between Nexalin Technology time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nexalin Technology price movement. The serial correlation of 0.46 indicates that about 46.0% of current Nexalin Technology price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.46 | |
| Spearman Rank Test | 0.31 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Nexalin Technology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Nexalin Technology Technical Analysis
The output start index for this execution was fifty with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Nexalin Technology volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Nexalin Technology Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Nexalin Technology on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Nexalin Technology based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Nexalin Technology price pattern first instead of the macroeconomic environment surrounding Nexalin Technology. By analyzing Nexalin Technology's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Nexalin Technology's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Nexalin Technology specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 0.16 | 0.23 | 0.27 | 0.31 | Days Of Inventory On Hand | 2.2K | 1.7K | 1.6K | 1.6K |
Nexalin Technology February 5, 2026 Technical Indicators
Most technical analysis of Nexalin help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Nexalin from various momentum indicators to cycle indicators. When you analyze Nexalin charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.18) | |||
| Market Risk Adjusted Performance | (0.47) | |||
| Mean Deviation | 3.9 | |||
| Coefficient Of Variation | (400.26) | |||
| Standard Deviation | 5.37 | |||
| Variance | 28.89 | |||
| Information Ratio | (0.26) | |||
| Jensen Alpha | (1.51) | |||
| Total Risk Alpha | (1.75) | |||
| Treynor Ratio | (0.48) | |||
| Maximum Drawdown | 27.45 | |||
| Value At Risk | (8.70) | |||
| Potential Upside | 7.92 | |||
| Skewness | 0.6008 | |||
| Kurtosis | 2.41 |
Nexalin Technology February 5, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Nexalin stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 873,909 | ||
| Daily Balance Of Power | 0.50 | ||
| Rate Of Daily Change | 1.09 | ||
| Day Median Price | 0.64 | ||
| Day Typical Price | 0.63 | ||
| Price Action Indicator | 0.01 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexalin Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in median. For more information on how to buy Nexalin Stock please use our How to buy in Nexalin Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexalin Technology. Anticipated expansion of Nexalin directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Nexalin Technology assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.65) | Revenue Per Share | Quarterly Revenue Growth (0.50) | Return On Assets | Return On Equity |
The market value of Nexalin Technology is measured differently than its book value, which is the value of Nexalin that is recorded on the company's balance sheet. Investors also form their own opinion of Nexalin Technology's value that differs from its market value or its book value, called intrinsic value, which is Nexalin Technology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexalin Technology's market value can be influenced by many factors that don't directly affect Nexalin Technology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Nexalin Technology's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nexalin Technology should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Nexalin Technology's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.